NCIRE - The Veterans Health Research Institute Home  |  Sitemap  |  Intranet  |  UltiPro   Visit our Facebook page  Visit our Twitter page  Visit our LinkedIn page

Give Now
About NCIRE Participate in Research Support Our Mission Careers at NCIRE Contact Us
Veterans Health
Research at NCIRE

NCIRE-The Veterans Health Research Institute is the leading private nonprofit institute devoted to Veterans health research in the United States. Our mission is to advance Veterans health through research.

We support the work of some of the nation's foremost physicians and scientists at the San Francisco Veterans Affairs Medical Center, the premier biomedical research facility in the VA system. All have faculty appointments at the University of California, San Francisco, which has its own proud traditions of research and patient care. We also partner with the U.S. Department of Defense to support health research on behalf of our men and women in the Armed Forces.

Those who have served in uniform have given their best for their country. In return, we believe that they deserve nothing less than the best health care research we can provide.

Contact Us
Give Now
Mary-Margaret Chren, MD

Staff Physician, Dermatology Service, SFVAHCS
Professor of Dermatology, UCSF


Comprehensive Outcomes of Chronic Diseases; Enhancing Health Services Research at SFVAMC

Dr. Chren is a health services investigator, internist, and dermatologist whose research has focused on understanding, measuring, and improving the health of patients with chronic diseases. She previously developed and validated a skin-related quality-of-life tool, Skindex, which is widely used and has been translated and adapted into over 15 languages. Her current studies measure complex health attributes, such as patients' experience of illness, their preferences, and quality of life, and then use those measurements and more conventional clinical assessments to assess health outcomes of chronic diseases.  She is director of a prospective study of a large cohort of patients diagnosed with nonmelanoma skin cancer - the most common malignancy - to determine long-term outcomes of different treatments.

To see Dr. Chren on Pub Med, click here.